The investment will help advance studies to validate polyproxin® molecules as potential drug candidates across a range of cancers.
Funding aims to progress strong discovery science to a point where additional substantive funding could be secured.
Translational research can turn promising science into new treatments for those with rare diseases. It’s why we…
LifeArc celebrates the UN’s International day of Women and Girls in Science, joining the call to remove any barriers that hold women back.
£1m for translational research projects focussed on children’s rare diseases
Graham Duce appointed to the newly created role of CIO to ensure that we have a sustainable approach to income generation
Melanie Lee, LifeArc CEO acknowledges the success of the life sciences and translational research sectors in the UK
A research grant to investigate the potential of a novel type of “personalised cellular therapy” to reverse the ultra-rare condition, aplastic anaemia
Investment to allow Caldan to translate work on free fatty acid receptors initiated in their laboratories